Gainers
- TransCode Therapeutics RNAZ stock rose 55.5% to $0.73 during Wednesday's regular session. As of 12:30 EST, TransCode Therapeutics's stock is trading at a volume of 35.8 million, which is 1131.1% of its average full-day volume over the last 100 days. The company's market cap stands at $9.4 million.
- Sera Prognostics SERA shares rose 38.92% to $1.82. As of 12:30 EST, this security is trading at a volume of 42.0 million shares, making up 152111.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $56.4 million.
- Organovo Holdings ONVO shares increased by 27.3% to $2.78. The current volume of 621.9K shares is 962.0% of Organovo Holdings's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $24.1 million. The company's, Q3 earnings came out 4 days ago.
- Vallon Pharmaceuticals VLON stock moved upwards by 26.19% to $0.82. Trading volume for Vallon Pharmaceuticals's stock is 39.8 million as of 12:30 EST. This is 519.4% of its average full-day volume over the last 100 days. The company's market cap stands at $11.0 million.
- Tenon Medical TNON stock rose 24.24% to $1.23. Trading volume for this security as of 12:30 EST is 9.5 million, which is 24840.7% of its average full-day volume over the last 100 days. The company's market cap stands at $13.8 million.
- Vapotherm VAPO stock moved upwards by 18.27% to $1.1. The current volume of 686.3K shares is 99.8% of Vapotherm's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $31.3 million.
Losers
- GlycoMimetics GLYC shares decreased by 55.6% to $1.8 during Wednesday's regular session. The current volume of 9.1 million shares is 835.1% of GlycoMimetics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $94.3 million.
- T2 Biosystems TTOO shares decreased by 22.26% to $0.84. As of 12:30 EST, T2 Biosystems's stock is trading at a volume of 3.1 million, which is 1171.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.1 million.
- Galera Therapeutics GRTX shares decreased by 17.77% to $1.62. Trading volume for Galera Therapeutics's stock is 2.0 million as of 12:30 EST. This is 1680.2% of its average full-day volume over the last 100 days. The company's market cap stands at $46.1 million.
- Entrada Therapeutics TRDA shares fell 16.04% to $10.94. As of 12:30 EST, this security is trading at a volume of 67.7K shares, making up 115.2% of its average full-day volume over the last 100 days. The company's market cap stands at $361.2 million.
- NeuBase Therapeutics NBSE shares decreased by 15.46% to $0.3. Trading volume for this security as of 12:30 EST is 442.1K, which is 125.6% of its average full-day volume over the last 100 days. The company's market cap stands at $10.0 million. The company's, Q1 earnings came out yesterday.
- Soligenix SNGX stock fell 14.53% to $4.06. The current volume of 79.0K shares is 452.4% of Soligenix's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $11.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
GRTXGalera Therapeutics Inc
$0.1380-4.83%
ONVOOrganovo Holdings Inc
$0.37230.03%
RNAZTransCode Therapeutics Inc
$3.83-0.52%
SERASera Prognostics Inc
$8.788.00%
SNGXSoligenix Inc
$2.95-4.22%
TNONTenon Medical Inc
$1.84-4.17%
TRDAEntrada Therapeutics Inc
$17.20-0.46%
TTOOT2 Biosystems Inc
$0.35004.76%
VAPOVapotherm Inc
$1.24-42.9%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in